Navigation Links
Dawning Technologies, Inc. Releases JavaLin/PDI Portable Device Interface
Date:5/12/2008

FORT MYERS, Fla., May 12 /PRNewswire/ -- Dawning Technologies, Inc. announces the release of their latest small footprint interface device in the new JavaLin/PDI Portable Device Interface. The JavaLin/PDI is the fifth generation of intelligent clinical interfaces from Dawning and provides an unparalleled range of features and capabilities primarily aimed at the connection of clinical instruments to information systems. Combining the power of JResultNet Interface Engine Software, embedded within the JavaLin/PDI, with a flexible hardware design, the JavaLin/PDI supports a variety of industry standard communication protocols and can run any of the applications in Dawning's Java Driver Library, now available for more than 400 instruments.

The PDI device provides 2 serial and 1 Ethernet port, allows users to connect one or two analyzers directly to the LIS network without need for terminal server devices. LIS communication can use HL7, ASTM, XML, CDF, flat file or direct database connection protocols, with complete message mapping controls.

The JavaLin/PDI advances the company's strategy of providing the clinical laboratory with scalable and flexible middleware solutions. Remotely accessible via a user friendly point-and-click GUI and comprehensible rules entry tools, the JavaLin/PDI answers common laboratory issues involving connectivity, efficiency, space and cost. The PDI hardware is a modular design that provides more power in a smaller footprint (approximately 3" x 5") than Dawning's previous devices and allows for future expandability.

Running the powerful Java-based JResultNet software embedded within the JavaLin/PDI enables the user to employ an array of functionality including rules based processing and message customization, complete message mapping control, a number of diagnostic features and much more. Optional features available include more advanced rules features, review/edit/release by exception controls, QC system integration and more.

About Dawning Technologies, Inc.

Dawning Technologies, Inc. is the leading supplier of connectivity solutions to the clinical laboratory market. In business since 1984, Dawning solutions are installed in over 3000 client sites worldwide. Their customers include information system vendors, IVD instrument manufacturers, POC system vendors and clinical laboratories of all forms. Dawning solutions are available for nearly all clinical analyzers, POC and system-to-system connections. For more information contact their web site at http://www.dawning.com .


'/>"/>
SOURCE Dawning Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
2. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
3. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
4. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
5. ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products
6. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
7. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
8. ReBuilder Medical Technologies, Inc. Announces Agreement with Internet Marketer Helio Health; Anticipates 12% Additional Profit
9. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
10. ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand
11. ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 percent ... cancer deaths. More than 10,000 people are expected to die of melanoma this year. The ... the one of the most commonly diagnosed cancers in young women. A recent breakthrough in ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... Innovations with Ed Begley ... upcoming episode, airing third quarter 2016 via Discovery Channel. Dates and show times ... Dairy Products, located in Greenwood, Wisconsin applies product research and development and continuous ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at ... Sanaz Ghazal, and Dr. Daniel A. Potter -- are proud of the recent release ... Technology (SART). In April, SART published the latest verified data for 375 ...
(Date:4/29/2016)... ... April 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend ... 4 at the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event ... technologies for protein ingredients. , At the seminar, IDF™ will offer samples of its ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  Marking its one year anniversary ... ovarian cancer risk test, Color Genomics ... that highly impact the most common hereditary cancers ... Color Test analyzes hereditary cancer risks for breast, ... cancers. The Color Test is physician ordered and ...
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
(Date:4/28/2016)... WARSAW, Ind., April 28, 2016 , Net ... a reported basis over the prior year period, and an ... basis , Diluted EPS for the first quarter were ... period, and $2.00 adjusted, an increase of 29.9% over the ... revenue and adjusted earnings guidance for 2016 Zimmer ...
Breaking Medicine Technology: